Medicare Enrolled
Dr. Christopher Pace, MD
Urology Physician · Grapevine, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Pace from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pace?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pace
Dr. Christopher Pace is an urology physician in Grapevine, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Pace performed 2,100 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Pace received a total of $3,392 from 41 pharmaceutical and/or device companies across 145 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pace is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 47% volume in TX
$3,392 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,100
Medicare services
Top 47% in TX for urology physician
Not available
Unique patients (not deduplicated)
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
423 | $2 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
383 | $87 | $281 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
243 | $8 | $24 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
147 | $115 | $360 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
85 | $7 | $14 |
| PSA test (prostate cancer screening) | 83 | $18 | $41 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
69 | $69 | $314 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
49 | $18 | $51 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
48 | $61 | $164 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
46 | $34 | $355 |
| Herpes simplex virus nucleic acid test A laboratory test that uses an amplified probe technique to detect the genetic material of the herpes simplex virus. |
46 | $34 | $197 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
46 | $34 | $117 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
40 | $65 | $210 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
36 | $18 | $41 |
| Online digital E/M service, established patient, 11-20 min An online digital evaluation and management service for an established patient. The service involves a total time of 11 to 20 minutes over a period of up to 7 days. |
29 | $20 | $61 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
28 | $119 | $1,113 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
23 | $179 | $523 |
| CMV nucleic acid detection test A laboratory test that uses amplified probe techniques to detect cytomegalovirus (CMV) genetic material in a sample. |
23 | $34 | $78 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
23 | $34 | $78 |
| Herpes virus-6 nucleic acid test A laboratory test that uses amplified probe techniques to detect the genetic material of herpes virus-6. |
23 | $34 | $78 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
23 | $34 | $78 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
23 | $34 | $78 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
23 | $34 | $78 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
22 | $136 | $391 |
| Online digital evaluation for established patient, 5-10 minutes This service involves an online digital evaluation and management visit for an established patient. It covers a total time of 5 to 10 minutes over a period of up to 7 days. |
22 | $11 | $31 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
18 | $25 | $57 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
18 | $102 | $289 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
17 | $3 | $8 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
16 | $67 | $242 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $132 | $405 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
12 | $19 | $164 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
1.3% high complexity
12.1% medium
86.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,392
Total received (2018-2024)
Avg $485/year across 7 years
Top 48% in TX for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
145
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$777
2023
$710
2022
$476
2021
$341
2020
$263
2019
$416
2018
$410
Payments by company (2024)
Janssen Biotech, Inc.
$131
ABBVIE INC.
$105
Endo USA, Inc.
$88
Olympus America Inc.
$84
Axonics, Inc.
$60
Boston Scientific Corporation
$59
Merck Sharp & Dohme LLC
$47
UROGEN PHARMA, INC.
$44
Blue Earth Diagnostics Limited
$43
PROGENICS PHARMACEUTICALS, INC.
$25
PFIZER INC.
$20
COLOPLAST CORP
$20
Sumitomo Pharma America, Inc.
$19
ACCORD HEALTHCARE, INC.
$18
Verity Pharmaceuticals Inc.
$14
Top 3 companies account for 41.8% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$408
ABBVIE INC.
$316
PFIZER INC.
$310
Boston Scientific Corporation
$273
Janssen Biotech, Inc.
$211
Axonics, Inc.
$165
BOSTON SCIENTIFIC CORPORATION
$127
Coloplast Corp
$122
Blue Earth Diagnostics Limited
$118
Olympus America Inc.
$100
Endo Pharmaceuticals Inc.
$99
ACCORD HEALTHCARE, INC.
$95
Endo USA, Inc.
$88
Sumitomo Pharma America, Inc.
$83
Merck Sharp & Dohme LLC
$71
Janssen Scientific Affairs, LLC
$70
COLOPLAST CORP
$64
UroGen Pharma, Inc.
$63
Ferring Pharmaceuticals Inc.
$61
MEDIVATION FIELD SOLUTIONS LLC
$59
UROGEN PHARMA, INC.
$44
AbbVie Inc.
$36
TherapeuticsMD, Inc.
$36
AbbVie, Inc.
$36
Kowa Pharmaceuticals America, Inc.
$34
Antares Pharma, Inc.
$31
Verity Pharmaceuticals Inc.
$27
PROGENICS PHARMACEUTICALS, INC.
$25
Accord Healthcare, Inc.
$22
Bayer HealthCare Pharmaceuticals Inc.
$20
Myovant Sciences Inc.
$20
Progenics Pharmaceuticals, Inc.
$20
Biocomposites Inc
$19
Avadel Specialty Pharmaceuticals, LLC
$18
Supernus Pharmaceuticals, Inc.
$18
Amgen Inc.
$16
TOLMAR Pharmaceuticals, Inc.
$15
Tolmar, Inc.
$14
GENZYME CORPORATION
$14
ACELL, INC.
$12
180 Medical, Inc.
$11
Top 3 companies account for 30.4% of all-time payments
Associated products mentioned in payments ›
ANNOVERA · AVEED · Axonics · Axumin · BOTOX · Bulkamid · CAMCEVI · Coloplast TFL Drive · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL BPH · GENERAL BPH · GENTLECATH · General - Therapies · Isiris · Isiris aStent Removal Device · JELMYTO · JEVTANA · KEYTRUDA · Kyleena · LO LOESTRIN FE · LUPRON DEPOT · LYNPARZA · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · ORGOVYX · POSLUMA · PYLARIFY · Prolia · ReTrace · Rezum Generator · SEGLENTIS · Stenostent · Stimulan · Trelstar · URETERO-RENO FIBERSCOPE · VESICARE · Veozah · XIAFLEX · XTANDI · XYOSTED · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
180
County median income
$81,905
Nearest hospital to ZIP centroid (approximate)
BAYLOR SCOTT & WHITE MEDICAL CENTER GRAPEVINE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Pace is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Pace experienced with automated urinalysis?
Based on Medicare claims data, Dr. Pace performed 423 automated urinalysis services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Pace receive payments from pharmaceutical companies?
Yes. Dr. Pace received a total of $3,392 from 41 companies across 145 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pace's costs compare to other urology physicians in Grapevine?
Dr. Pace's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pace) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Grapevine
Browse urology physicians in Grapevine ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology